DHL Medical Express Service has been launched between Brazil and the USA for customers in the pharmaceutical and clinical research sectors.
The service was piloted in Brazil in November 2018 to address customer demands for faster and more predictable lead times, given the regulatory complexities that can delay exports.
The medical service lets DHL manage the export and regulatory requirements for urgent shipments with specific temperature needs from several major Brazilian cities to most US destinations in 24 to 48 hours.
Service points in Brazil have been upgraded and validated to meet federal, state and city regulations around Ministry of Health and Sanitary controls and licencing requirements.
Mike Parra, CEO of DHL Express Americas says: “The launch of this service in Brazil completes our ambition to offer logistics solutions in the Latin and South American countries where most clinical trials are conducted. Our strong international network, compliant certifications and combination of responsiveness, reliability and cost-effectiveness will enable this service to be advantageous to all stakeholders in the clinical trial value chain.”
The implementation of the DHL Medical Express Service clinical trial platform at DHL Express Brazil includes a dedicated Customer Service Center with bilingual staff and an onboarding team to support investigator sites.
The service includes dry ice supplies and temperature-controlled fulfillment, online tools for placing bookings and ordering supplies, and a web-based interface that connects sites.
Brian Bralynski, director of life sciences healthcare Americas at DHL Express says: “Given the complexity of regulatory requirements in Brazil, our technology solution pre-prepares many of the necessary documents required by investigator sites to complete, while enabling DHL to begin the export and fiscal approval process the day-of- booking to mitigate delays.”